“In most industrialized countries, counterfeit medicines reach patients through the Internet and the regulated distribution chain. In order to be effective, anti-counterfeiting protection must be implemented as a collaborative effort throughout the supply chain and be open to government oversight.”- Dr. Valerio Reggi Executive Secretary, IMPACT, International Medical Products Anti-Counterfeiting Taskforce.
Our speaker faculty is comprised of industry leaders from manufacturing, distribution, federal and non-profit organizations who rarely come together to discuss their strategies for anti-counterfeiting protection.